drugset / Trial / NCT00065533
Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
The purposes of this study are to determine the safety of pemetrexed and any side effects that might be associated with it, whether pemetrexed can help patients with breast cancer and how much pemetrexed should be given to patients.
Timeline
- Start
- 2003-05
- Primary completion
- —
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pemetrexed | Small molecule | — | — |